Funding Opportunities
Current Funding Opportunities
| Title | NIH Guide | RFA Number | Common Fund Contact | Application Receipt Date |
|---|---|---|---|---|
| There are no funding opportunities at this time. |
|
Related Funding Opportunities
| Title | NIH Guide | RFA Number | Contact | Application Receipt Date |
|---|---|---|---|---|
| Commercializing Understudied Proteins from the Illuminating the Druggable Genome Project (IDG) (R41/R42 Clinical Trial Not Allowed) | 10/24/2018 | PA-19-033 | Karlie Sharma, PhD Telephone: 301-451-4965 Email: karlie.sharma@nih.gov |
Standard dates apply |
| Commercializing Understudied Proteins from the Illuminating the Druggable Genome Project (IDG) (R43/R44 Clinical Trial Not Allowed) | 10/24/2018 | PA-19-034 | R. Dwayne Lunsford, PhD Telephone: 301-451-4965 Email: karlie.sharma@nih.gov |
Standard dates apply |
Archived Funding Opportunities
- Pilot Projects Investigating Understudied G Protein-Coupled Receptors, Ion Channels, and Protein Kinases (R03 Clinical Trial Not Allowed)
RFA-RM-19-011 - Pilot Projects Investigating Understudied G Protein-Coupled Receptors, Ion Channels, and Protein Kinases (R03 Clinical Trial Not Allowed)
RFA-RM-18-021 - Cutting Edge Informatics Tools for Illuminating the Druggable Genome (U01 Clinical Trial Not Allowed)
RFA-RM-18-011 - Knowledge Management Center for Illuminating the Druggable Genome (U24)
RFA-RM-16-024 - Resource Dissemination and Outreach Center for Illuminating the Druggable Genome (U24)
RFA-RM-16-025 - Data and Resource Generation Centers for Illuminating the Druggable Genome (U24)
RFA-RM-16-026 - Request for Information (RFI): Input on Direction of the Second Phase of the "Illuminating the Druggable Genome" Program
NOT-RM-14-018 - Adaptation of Scalable Technologies to Illuminate the Druggable Genome (U01)
RFA-RM-13-010 - Development of a Knowledge Management Center for Illuminating the Druggable GenomeTitle Here (U54)
RFA-RM-13-011 - Pilot Projects Investigating Understudied G Protein-Coupled Receptors, Ion Channels, and Protein Kinases (R03 Clinical Trial Not Allowed) RFA-RM-19-011
This page last reviewed on March 29, 2020